Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients

Psychotic disorders are currently diagnosed by examining the patient’s mental state and medical history. Identifying reliable diagnostic, monitoring, predictive, or prognostic biomarkers would be useful in clinical settings and help to understand the pathophysiology of schizophrenia. Here, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Pei, Ho, Ada Man-Choi, Tufvesson-Alm, Maximilian, Lindberg, Daniel R., Grant, Caroline W., Orhan, Funda, Eren, Feride, Bhat, Maria, Engberg, Göran, Schwieler, Lilly, Fatouros-Bergman, Helena, Imbeault, Sophie, Iverson, Ryan M., Dasari, Surendra, Piehl, Fredrik, Cervenka, Simon, Sellgren, Carl M., Erhardt, Sophie, Choi, Doo-Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166796/
https://www.ncbi.nlm.nih.gov/pubmed/35665740
http://dx.doi.org/10.1038/s41398-022-02000-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166796/
https://www.ncbi.nlm.nih.gov/pubmed/35665740
http://dx.doi.org/10.1038/s41398-022-02000-1

Ejemplares similares